CoChat

Chitinase enzyme activity in CSF is a powerful biomarker of Alzheimer disease

Open access
Watabe-Rudolph, M., Song, Z., Lausser, L., Schnack, C., Begus-Nahrmann, Y., Scheithauer, M.-O., Rettinger, G., Otto, M., Tumani, H., Thal, D.R., Attems, J., Jellinger, K.A., Kestler, H.A., von Arnim, C.A.F., Rudolph, K.L. · 2012 · Neurology
Cited by 116

The DOI matches its Crossref record; 17 of the 17 references it cites were found in a registry or an index.

Abstract

OBJECTIVE: DNA damage accumulation in brain is associated with the development of Alzheimer disease (AD), but newly identified protein markers of DNA damage have not been evaluated in the diagnosis of AD and other forms of dementia. METHODS: Here, we analyzed the level of novel biomarkers of DNA damage and telomere dysfunction (chitinase activity, N-acetyl-glucosaminidase activity, stathmin, and EF-1α) in CSF of 94 patients with AD, 41 patients with non-AD dementia, and 40 control patients without dementia. RESULTS: Enzymatic activity of chitinase (chitotriosidase activity) and stathmin protein level were significantly increased in CSF of patients with AD and non-AD dementia compared with that of no dementia control patients. As a single marker, chitinase activity was most powerful for distinguishing patients with AD from no dementia patients with an accuracy of 85.8% using a single threshold. Discrimination was even superior to clinically standard CSF markers that showed an accuracy of 78.4% (β-amyloid) and 77.6% (tau). Combined analysis of chitinase with other markers increased the accuracy to a maximum of 91%. The biomarkers of DNA damage were also increased in CSF of patients with non-AD dementia compared with no dementia patients, and the new biomarkers improved the diagnosis of non-AD dementia as well as the discrimination of AD from non-AD dementia. CONCLUSIONS: Taken together, the findings in this study provide experimental evidence that DNA damage markers are significantly increased in AD and non-AD dementia. The biomarkers identified outperformed the standard CSF markers for diagnosing AD and non-AD dementia in the cohort investigated.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1212/wnl.0b013e318247caa1

Cites

17 of 17 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 17 references

Cited by

See all 116

Metadata

Authors
Watabe-Rudolph, M., Song, Z., Lausser, L., Schnack, C., Begus-Nahrmann, Y., Scheithauer, M.-O., Rettinger, G., Otto, M., Tumani, H., Thal, D. R., Attems, J., Jellinger, K. A., Kestler, H. A., von Arnim, C. A. F., & Rudolph, K. L.
Venue
Neurology
Published
2012-02-21
Volume
78
Issue
8
Pages
569-577
ISSN
  • 0028-3878 (ISSN-L)
  • 1526-632X
OpenAlex
W2075254065
Cited by
116
References
17
FWCI
7.58
Type
journal article
Language
en
Open access
green

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Chitinase enzyme activity in CSF is a powerful biomarker of Alzheimer disease. https://app.cochat.ai/papers/10.1212/wnl.0b013e318247caa1
The paper
Watabe-Rudolph, M., Song, Z., Lausser, L., Schnack, C., Begus-Nahrmann, Y., Scheithauer, M.-O., Rettinger, G., Otto, M., Tumani, H., Thal, D. R., Attems, J., Jellinger, K. A., Kestler, H. A., von Arnim, C. A. F., & Rudolph, K. L. (2012). Chitinase enzyme activity in CSF is a powerful biomarker of Alzheimer disease. Neurology. https://doi.org/10.1212/wnl.0b013e318247caa1

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.